Comparing the efficacy of three bioceramic matrices for the release of vancomycin hydrochloride
A number of calcium phosphate materials have been investigated as drug release matrices for the prophylactic treatment of implant‐related osteomyelitis. However, some studies have shown the influence of processing on the efficacy of the delivered drug. The objective of this study was to evaluate the...
Saved in:
Published in | Journal of biomedical materials research. Part B, Applied biomaterials Vol. 93B; no. 1; pp. 51 - 58 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Hoboken
Wiley Subscription Services, Inc., A Wiley Company
01.04.2010
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | A number of calcium phosphate materials have been investigated as drug release matrices for the prophylactic treatment of implant‐related osteomyelitis. However, some studies have shown the influence of processing on the efficacy of the delivered drug. The objective of this study was to evaluate the influence of pH during processing on the efficacy of vancomycin hydrochloride (VH) against Staphylococcus aureus. VH was loaded into a brushite cement (CaHPO4·2H2O; pH 2.4); a hydroxyapatite cement (Ca10(PO4)6OH2; pH 9.4); and an apatite xerogel (pH 7.4). The pH of the material during processing had a significant influence on the mechanism of release from the cement. VH released from the apatite cement (pH 9.4) was not released in accordance with the Higuchi model. In addition to affecting release, the basic pH was shown to diminish the antibacterial potency of the released VH. Despite exceeding the minimum inhibitory concentration, the eluent from the apatite cement was ineffective against a culture of S. aureus. The findings of this study reinforce the importance of evaluating not only the release of the drug from the material matrix but also the antibacterial potency of the released drug. © 2009 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2010 |
---|---|
Bibliography: | ArticleID:JBM31557 istex:213CD4C16D66DA05F59A08A223E48A2C32353156 ark:/67375/WNG-41K3TKV3-V Advantage West Midlands (AWM) European Regional Development Fund (ERDF) These authors contribued equally to this work. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1552-4973 1552-4981 1552-4981 |
DOI: | 10.1002/jbm.b.31557 |